What is Interpath Laboratory?
Interpath Laboratory operates as a family-owned, independent medical laboratory providing comprehensive diagnostic services, including blood draws and specialized pathology. By integrating advanced technology with a patient-centric approach, the company serves a diverse ecosystem of hospitals, clinics, and individual patients. Their proprietary platform, InterpathDirect, represents a strategic pivot toward direct-to-consumer health solutions, effectively bridging the gap between traditional clinical diagnostics and modern, accessible healthcare. The firm maintains a competitive edge by prioritizing rapid turnaround times and cost-effective testing protocols, ensuring high-quality outcomes in a demanding medical landscape.
How much funding has Interpath Laboratory raised?
Interpath Laboratory has raised a total of $2M across 1 funding round:
Debt
$2M
Debt (2020): $2M with participation from PPP
Key Investors in Interpath Laboratory
PPP
Public-Private Partnership
What's next for Interpath Laboratory?
With this major enterprise-level funding, Interpath Laboratory is well-positioned to accelerate its digital transformation and expand its diagnostic footprint. The strategic allocation of capital will likely focus on upgrading laboratory automation, scaling the InterpathDirect platform, and potentially pursuing regional consolidation to maintain its dominance in the Pacific Northwest. By focusing on technological integration and personalized care, the company is poised to navigate the evolving regulatory environment while continuing to provide essential diagnostic support to the healthcare community at large.
See full Interpath Laboratory company page
